Previous 10 | Next 10 |
home / stock / tevjf / tevjf news
Summary As a leader in various therapeutic areas, the company's total revenue was $7,042 million in the third quarter of 2022, up 12.5% quarter-on-quarter. Gilead will be required to make royalties of 3% on future sales of Biktarvy and bictegravir-containing medicines up to the 4th quar...
Summary TEVA's undoing was its $40.5 billion deal to acquire Allergan's generic drug business in 2015. It has never achieved the financial results it was hoping for from the deal and the stock has not recovered to former glories after imploding in 2018. The turnaround plan that has ...
Summary I love to get a CVR during a takeover process. This happens a lot when pharma or biotech companies with important unapproved assets get bought. The CVR helps to bridge the gap between the price the seller wants and the buyer wants to pay. They are always uniquely structu...
Teva Pharmaceutical Industries Ltd. (TEVA) 41st Annual J.P. Morgan Healthcare Conference January 11, 2023 1:30 PM ET Company Participants Eli Kalif - Executive Vice President and Chief Financial Officer Richard Francis - President and CEO Conference Call Participants...
Summary Despite settling one of its disputes surrounding the Korlym label, investors were major sellers of Corcept equity in Q4 FY22. Question is, does the selloff represent a value proposition, and do current valuations make sense. On close inspection, we believe that paying 21x fo...
Summary David Abrams’ 13F portfolio value decreased this quarter from $3.72B to $3.47B. The number of positions remained steady at 18. The Kinder Morgan stake was reduced substantially this quarter. The top three positions are Lithia Motors, Change Healthcare, and Ashbu...
Summary Legal cannabis around the world is just beginning but will surpass that of North America. Europe is one of the largest growth markets for companies in global cannabis. InterCure is well positioned to take advantage of European cannabis growth. For...
Teva Pharmaceutical Industries Limited (TEVA) Q3 2022 Earnings Conference Call November 03, 2022, 08:00 AM ET Company Participants Ran Meir - Senior Vice President, Head of Investor Relations Kare Schultz - President and Chief Executive Officer Eli Kalif - Execut...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2022 Q3 earnings call. For further details see: Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation
Summary Calamos offers seven different closed-end funds, all with some overlap. CHY and CHI seem to have the most overlap of the group. Today, we are looking at just how similar they are and deciding if either is a better deal at this time. Written by Nick Ackerman, co...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Ltd Company Name:
TEVJF Stock Symbol:
OTCMKTS Market:
Teva Pharmaceutical Industries Ltd Website: